Sei Investments Co. Boosts Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Sei Investments Co. raised its stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 22.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,471 shares of the company’s stock after buying an additional 7,731 shares during the quarter. Sei Investments Co. owned about 0.15% of Establishment Labs worth $1,957,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the stock. William Blair Investment Management LLC increased its stake in Establishment Labs by 44.1% in the 4th quarter. William Blair Investment Management LLC now owns 812,825 shares of the company’s stock worth $37,447,000 after acquiring an additional 248,888 shares during the last quarter. Assenagon Asset Management S.A. bought a new stake in Establishment Labs in the fourth quarter worth $12,898,000. Raymond James Financial Inc. purchased a new stake in Establishment Labs during the fourth quarter valued at $5,494,000. Royce & Associates LP bought a new position in Establishment Labs during the fourth quarter valued at $4,862,000. Finally, Point72 Asset Management L.P. grew its stake in shares of Establishment Labs by 210.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 49,400 shares of the company’s stock worth $2,138,000 after buying an additional 33,507 shares in the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Trading Down 4.6 %

Shares of ESTA opened at $32.30 on Friday. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a twelve month low of $28.16 and a twelve month high of $60.12. The company has a market cap of $931.73 million, a P/E ratio of -12.52 and a beta of 0.77. The company’s fifty day simple moving average is $36.67 and its 200-day simple moving average is $40.62.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The company had revenue of $44.51 million during the quarter, compared to analysts’ expectations of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. As a group, analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Stephens reiterated an “overweight” rating and issued a $52.00 price target on shares of Establishment Labs in a research report on Thursday, March 6th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $57.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.